Ascendis Pharma AS ASND Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Total Assets	1.09B	966.27M	823.82M	873.21M	825.59M	802.5M	758.3M	1.09B
Total Current Assets	923.47M	809.85M	677.68M	732.93M	702.72M	664.11M	627.32M	973.74M
Cash and Equivalents	444.77M	501.28M	394.22M	441.27M	392.16M	320.24M	258.7M	625.52M
Total Non-Current Assets	295.36M	284.19M	271.51M	265.82M	66.88M	245.56M	235.02M	217.57M
Total Liabilities	826.39M	799.07M	758.98M	946.65M	971.28M	1.04B	1.08B	1.19B
Total Current Liabilities	171.27M	198.36M	192.27M	212.76M	197.34M	798.97M	847.74M	838.46M
Total Non-Current Liabilities	1.14B	1.08B	1.05B	1.37B	1.39B	471.34M	450.75M	691.58M
Common Equity	7.68M	7.7M	7.7M	7.74M	7.75M	7.82M	7.82M	8.14M
Retained Earnings	0	-1.96B	-2.06B	-2.2B	-2.28B	0	0	-2.55B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Total Assets	190.07M	210.98M	318.97M	676.73M	979.79M	1.08B	1.09B	825.59M
Total Current Assets	183.96M	204.63M	292.91M	611.17M	740.13M	805.89M	923.47M	702.72M
Cash and Equivalents	180.33M	195.35M	277.86M	598.11M	581.87M	441.74M	427.81M	392.16M
Total Non-Current Assets	176.61M	187.21M	280.05M	597.11M	838.71M	883.64M	263.35M	-145.7M
Total Liabilities	13.46M	23.77M	38.92M	79.62M	141.08M	201.29M	826.39M	971.28M
Total Current Liabilities	13.46M	23.77M	38.92M	47.99M	52.8M	100.36M	171.27M	197.34M
Total Non-Current Liabilities	0	0	0	62.35M	173.39M	198.9M	1.14B	1.39B
Total Equity	176.61M	187.21M	280.05M	597.11M	838.71M	883.64M	263.35M	-145.7M
Common Equity	4.35M	4.97M	5.66M	6.44M	7.22M	7.65M	7.68M	7.75M
Retained Earnings	159.25M	-263.21M	-393.31M	-611.32M	-1.03B	-1.41B	-1.86B	-2.28B